Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin C Pritchard

Showing results (71-80 of 172) with videos related to

Pageof 18
Sort By:
The Journal of Pathology|April 18, 2019
Intraductal carcinoma of the prostate in the absence of high-grade invasive carcinoma represents a molecularly distinct type of in situ carcinoma enriched with oncogenic driver mutationsFrancesca Khani, Sara E Wobker, Jessica L Hicks, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 4, 2020
Complexities of Next-Generation Sequencing in Solid Tumors: Case StudiesAlexandra O Sokolova, Brian H Shirts, Eric Q Konnick, et al.
European Urology|September 4, 2016
DNA Repair in Prostate Cancer: Biology and Clinical ImplicationsJoaquin Mateo, Gunther Boysen, Christopher E Barbieri, et al.
American Journal of Human Genetics|June 12, 2018
Using Somatic Mutations from Tumors to Classify Variants in Mismatch Repair GenesBrian H Shirts, Eric Q Konnick, Sarah Upham, et al.
Practical Laboratory Medicine|March 4, 2020
Validation and implementation of a modular targeted capture assay for the detection of clinically significant molecular oncology alterationsAyako J Kuo, Vera A Paulson, Jennifer A Hempelmann, et al.
Plos One|June 14, 2013
Plasma processing conditions substantially influence circulating microRNA biomarker levelsHeather H Cheng, Hye Son Yi, Yeonju Kim, et al.
The Prostate|June 22, 2016
A Pilot Study of Clinical Targeted Next Generation Sequencing for Prostate Cancer: Consequences for Treatment and Genetic CounselingHeather H Cheng, Nola Klemfuss, Bruce Montgomery, et al.
The American Journal of Surgical Pathology|February 12, 2020
Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. I. Molecular Biomarkers in Prostate CancerTamara L Lotan, Scott A Tomlins, Tarek A Bismar, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 29, 2014
Deep sequencing with intronic capture enables identification of an APC exon 10 inversion in a patient with polyposisBrian H Shirts, Stephen J Salipante, Silvia Casadei, et al.
Advances in Radiation Oncology|March 31, 2025
Long-Term Survival Following Chemoradiation in Locoregional Recurrent Germline <i>ATM</i> Mutated Pancreatic Ductal AdenocarcinomaRachael A Safyan, Keven Zhang, Smith Apisarnthanarax, et al.
Pageof 18

Showing results (71-80 of 172) with videos related to

Sort By:
Pageof 18
The Journal of Pathology|April 18, 2019
Intraductal carcinoma of the prostate in the absence of high-grade invasive carcinoma represents a molecularly distinct type of in situ carcinoma enriched with oncogenic driver mutationsFrancesca Khani, Sara E Wobker, Jessica L Hicks, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|September 4, 2020
Complexities of Next-Generation Sequencing in Solid Tumors: Case StudiesAlexandra O Sokolova, Brian H Shirts, Eric Q Konnick, et al.
European Urology|September 4, 2016
DNA Repair in Prostate Cancer: Biology and Clinical ImplicationsJoaquin Mateo, Gunther Boysen, Christopher E Barbieri, et al.
American Journal of Human Genetics|June 12, 2018
Using Somatic Mutations from Tumors to Classify Variants in Mismatch Repair GenesBrian H Shirts, Eric Q Konnick, Sarah Upham, et al.
Practical Laboratory Medicine|March 4, 2020
Validation and implementation of a modular targeted capture assay for the detection of clinically significant molecular oncology alterationsAyako J Kuo, Vera A Paulson, Jennifer A Hempelmann, et al.
Plos One|June 14, 2013
Plasma processing conditions substantially influence circulating microRNA biomarker levelsHeather H Cheng, Hye Son Yi, Yeonju Kim, et al.
The Prostate|June 22, 2016
A Pilot Study of Clinical Targeted Next Generation Sequencing for Prostate Cancer: Consequences for Treatment and Genetic CounselingHeather H Cheng, Nola Klemfuss, Bruce Montgomery, et al.
The American Journal of Surgical Pathology|February 12, 2020
Report From the International Society of Urological Pathology (ISUP) Consultation Conference on Molecular Pathology of Urogenital Cancers. I. Molecular Biomarkers in Prostate CancerTamara L Lotan, Scott A Tomlins, Tarek A Bismar, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 29, 2014
Deep sequencing with intronic capture enables identification of an APC exon 10 inversion in a patient with polyposisBrian H Shirts, Stephen J Salipante, Silvia Casadei, et al.
Advances in Radiation Oncology|March 31, 2025
Long-Term Survival Following Chemoradiation in Locoregional Recurrent Germline <i>ATM</i> Mutated Pancreatic Ductal AdenocarcinomaRachael A Safyan, Keven Zhang, Smith Apisarnthanarax, et al.
Pageof 18